DigitalEPI - A Prospective Pilot Study
Sponsor: AIT Austrian Institute of Technology GmbH
Terminated
Funding problems.
This NA trial investigates Epilepsy and is currently terminated or withdrawn. AIT Austrian Institute of Technology GmbH leads this study, which shows 9 recorded versions since 2024 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
9 versions recorded-
Feb 2026 — Present [monthly]
Terminated NA
Status: Unknown → Terminated
-
Dec 2025 — Feb 2026 [monthly]
Unknown NA
Status: Recruiting → Unknown
-
Sep 2024 — Dec 2025 [monthly]
Recruiting NA
-
Jul 2024 — Sep 2024 [monthly]
Recruiting NA
-
Nov 2023 — Jul 2024 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
▶ Show 4 earlier versions
-
Oct 2023 — Nov 2023 [monthly]
Not Yet Recruiting NA
-
Sep 2023 — Oct 2023 [monthly]
Not Yet Recruiting NA
-
Aug 2023 — Sep 2023 [monthly]
Not Yet Recruiting NA
-
Mar 2023 — Aug 2023 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- AIT Austrian Institute of Technology GmbH
- Brainhero GmbH
- Karl Landsteiner Institute for Clinical Epilepsy Research and Cognitive Neurology
For direct contact, visit the study record on ClinicalTrials.gov .